Funding news
BioSim Innovations logo

BioSim Innovations Secures $22.3M Series B Funding

Recently funded · $22.3M Series bTechnology, Information and MediaUSView source

Get the full BioSim Innovations company profile

Access contacts, investors, buying signals & more

Open in Dashboard

BioSim Innovations, a contract research and development organization that connects engineering principles to clinically relevant experiences for device and therapy evaluation, has closed a $22.3M Series b funding round. The capital infusion marks a significant step for the firm, which embraces the challenge of designing and delivering efficient, synergistic, and strategic studies.

This fresh investment will enable BioSim Innovations to further its specialized R&D support, helping clients navigate the complex landscape of medical device and therapy development. The funding underscores the growing demand for its expertise in creating robust evaluation frameworks.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
Solarscale (US) logo

Solarscale (US)

United States

$21.3M
2
Neuralink logo

Neuralink

United States

$28.7M
3
Insight Medbotics logo

Insight Medbotics

Canada

$37.2M
4
SolarTech Fotovoltaice logo

SolarTech Fotovoltaice

Romania

$35.0M
5
BioTechX logo

BioTechX

Switzerland

$45.0M